| 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | 2,3 M € | +1.3% | 2,3 M € | -4.6% | 2,4 M € | +2.4% | 2,4 M € | +1.7% | 2,3 M € | +50.5% | 1,5 M € | +10.7% | 1,4 M € | ||||||
| Gross margin | 294,5 k € | -10.0% | 327,2 k € | +13.5% | 288,4 k € | -3.2% | 298,1 k € | -33.5% | 448,4 k € | -26.5% | 610,1 k € | +39.5% | 437,5 k € | -21.4% | 556,5 k € | +14.2% | 487,5 k € | -14.4% | 569,7 k € | +227.5% | 174,0 k € | -43.9% | 310,1 k € | |
| EBITDA | 150,8 k € | -5.8% | 160,1 k € | +11.4% | 143,7 k € | -25.8% | 193,7 k € | +12.0% | 172,9 k € | -4.5% | 181,0 k € | +250.8% | 51,6 k € | -69.4% | 168,8 k € | +41.8% | 119,1 k € | -45.6% | 218,7 k € | +529.1% | -51,0 k € | -137.2% | 137,0 k € | |
| Operating profit | 73,3 k € | -11.7% | 83,0 k € | +27.6% | 65,1 k € | -20.5% | 81,9 k € | +379.4% | -29,3 k € | -55.3% | -18,9 k € | +88.1% | -158,3 k € | -1138.5% | 15,2 k € | +2927.5% | -539,0 € | -100.5% | 104,9 k € | +160.1% | -174,5 k € | -709.6% | 28,6 k € | |
| Profit/loss | 61,2 k € | -26.7% | 83,5 k € | +27.2% | 65,7 k € | -21.0% | 83,1 k € | +4648.1% | -1,8 k € | +97.3% | -66,9 k € | +65.9% | -196,2 k € | -234.5% | -58,7 k € | -210.0% | -18,9 k € | -124.7% | 76,6 k € | +138.1% | -200,8 k € | -1012.6% | 22,0 k € | |
| Equity | 935,6 k € | +7.0% | 874,4 k € | +10.6% | 790,9 k € | +9.1% | 725,2 k € | -18.9% | 894,7 k € | -0.2% | 896,5 k € | -6.9% | 963,4 k € | -16.9% | 1,2 M € | -4.8% | 1,2 M € | +413.7% | 237,2 k € | +47.7% | 160,5 k € | +295.4% | 40,6 k € | |
| Total assets | 2,3 M € | +48.7% | 1,5 M € | -5.5% | 1,6 M € | +0.5% | 1,6 M € | -21.8% | 2,1 M € | +21.9% | 1,7 M € | -19.7% | 2,1 M € | -7.9% | 2,3 M € | +2.1% | 2,2 M € | +75.1% | 1,3 M € | -20.6% | 1,6 M € | +71.3% | 940,8 k € | |
| Cash | 431,3 k € | +68.5% | 255,9 k € | -8.8% | 280,5 k € | +35.9% | 206,4 k € | +15.2% | 179,2 k € | -42.8% | 313,4 k € | -12.8% | 359,5 k € | -57.8% | 851,7 k € | -30.5% | 1,2 M € | +448.8% | 223,3 k € | -10.1% | 248,2 k € | +371.3% | 52,7 k € | |
| Debts | 1,3 M € | +102.9% | 655,8 k € | -20.9% | 829,0 k € | -6.5% | 886,6 k € | -24.1% | 1,2 M € | +51.8% | 769,3 k € | -32.6% | 1,1 M € | +1.3% | 1,1 M € | +15.4% | 977,2 k € | -6.2% | 1,0 M € | -28.2% | 1,5 M € | +61.2% | 900,2 k € | |
| Staff | 1,3 | 2,4 | 2,3 | 2 | — | 6 | 5,6 | 5 | 5,1 | 5 | 1,3 | 3,1 | ||||||||||||
Private limited company · Oudenaarde · incorporated on 16/01/2012 · 1,3 ETP
Private limited company profitable and well capitalised. Cash position rising (+68.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DECAPHAR is a Private limited company incorporated in 2012. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Oudenaarde. It employs on average 1,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette